Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Details for Australian Patent Application No. 2005266460 (hide)

Owner Aventis Pharma S.A.

Inventors Nemecek, Conception; Strobel, Hartmut; Bouchard, Herve; El-Ahmad, Youssef; Benard, Didier; Lebrun, Anne; Lesuisse, Dominique; Ruf, Sven; Guessregen, Stefan; Ritter, Kurt; Hittinger, Augustin

Agent A J Park

Pub. Number AU-A-2005266460

PCT Pub. Number WO2006/010641

Priority 04291904.3 27.07.04 EP

Filing date 25 July 2005

Wipo publication date 2 February 2006

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/010641 Priority application(s): WO2006/010641

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266461-Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

2005266459-Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility